Skip to main content
Intermediate Technical IVT

actionability

The degree to which a molecular finding can inform specific therapeutic interventions or clinical decisions.

Full Definition

Actionability refers to the clinical utility of molecular alterations detected in tumor profiling, specifically their ability to guide treatment selection or clinical management. Actionable alterations are those with established therapeutic implications, either through FDA-approved targeted therapies, strong clinical evidence, or enrollment opportunities in relevant clinical trials. The concept encompasses multiple levels of evidence, from definitive biomarkers with regulatory approval to emerging targets with preliminary data. Actionability assessment is crucial in precision oncology for prioritizing findings in complex molecular reports and ensuring that detected alterations translate into meaningful clinical benefit for patients.

Usage

Usage note: Use consistently in molecular reporting; avoid 'actionable' as a standalone term without context

In Context

  • "The mutation's actionability was limited due to lack of approved targeted therapies." — Molecular tumor board discussion
  • "Guidelines for assessing actionability should consider both approved drugs and clinical trial availability." — Laboratory standards document

Also known as

clinical actionability therapeutic actionability

Contrasted with

non-actionability

Don't confuse with

targetability druggability clinical significance

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON